Search Results

Displaying Results 1-6 of 6 "'AMLX'"

Jul 03, 2026, 12:15 ET Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

-- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders.

More news about: Halper Sadeh LLP


Apr 09, 2026, 19:54 ET Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

-- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders.

More news about: Halper Sadeh LLP


Jan 29, 2026, 17:05 ET HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

-- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders.

More news about: Halper Sadeh LLP


Nov 28, 2025, 18:40 ET HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

-- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders.

More news about: Halper Sadeh LLP


Oct 22, 2025, 10:13 ET Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm

PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders. 

More news about: Kuehn Law, PLLC


Oct 06, 2025, 12:25 ET Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm

PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders. 

More news about: Kuehn Law, PLLC


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.